Mary Patricia Smith,Karen Ly,Quinn Thibodeaux et al.
Mary Patricia Smith et al.
Acrodermatitis continua of Hallopeau (ACH) is a rare, sterile pustular eruption of one or more digits. The condition presents with tender pustules and underlying erythema on the tip of a digit, more frequently arising on a finger than a toe...
Mohamed Ibrahim El-Ghareeb,Afaf Helmy,Sally Al Kazzaz et al.
Mohamed Ibrahim El-Ghareeb et al.
Background: The proallergic cytokine, thymic stromal lymphopoietin (TSLP) may synergize with T cell-derived CD40 ligand (CD40L) to allow IL-23 production in patients with psoriasis. IL-23 is a central cytokine that mediat...
Karen Ly,Kristen M Beck,Mary P Smith et al.
Karen Ly et al.
Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening variant of psoriasis that is characterized by recurrent, acute onset, widely distributed pustular eruptions on inflamed, erythematous skin. It is important to r...
Investigation of psoriasis skin tissue by label-free multi-modal imaging: a case study on a phototherapy-treated patient [0.03%]
无标签多模态成像技术在银屑病皮损检测中的应用研究——以光疗患者为例
Nisha Rani Agarwal,Masoumeh Dowlatshahi Pour,Maria Siekkeri Vandikas et al.
Nisha Rani Agarwal et al.
Background: Psoriasis is a systemic inflammatory disease characterized by epidermal proliferation in the skin. Altered lipid metabolism is considered to be a central factor in the psoriatic etiopathogenesis. Thus, it is necessary to visuali...
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [0.03%]
用于治疗中度至重度斑块状银屑病和银屑病关节炎的新型疗法：评估BIMEKIZUMAB及其潜在疗效
Andrea Chiricozzi,Clara De Simone,Barbara Fossati et al.
Andrea Chiricozzi et al.
Plaque psoriasis (PsO) is a chronic inflammatory skin disorder that may be associated with several comorbidities, including arthritis. The increasing knowledge of psoriasis pathogenesis led to the identification of novel targeted therapeuti...
Spotlight on itolizumab in the treatment of psoriasis - current perspectives from India [0.03%]
有关艾托珠单抗治疗银屑病的印度现状及展望
Leelavathy Budamakuntla,H V Shree-Lakshmi,Akshi Bansal et al.
Leelavathy Budamakuntla et al.
Psoriasis is a chronic, debilitating, immune-mediated, systemic inflammatory disease affecting mainly skin, nails, and joints. Several therapeutic modalities are available depending on the severity of the disease. Long-term use of these dru...
Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris [0.03%]
寻常型银屑病患者皮肤HMGB1表达及T细胞DNA受体RAGE的表达变化
Lisa Strohbuecker,Hans Koenen,Esther van Rijssen et al.
Lisa Strohbuecker et al.
Purpose: Psoriasis vulgaris (PV) is an autoimmune-related chronic inflammatory disease of the skin, with both vascular and metabolic effects. Aggravating factors have been identified that initiate and maintain inflammatio...
Jesper Grønlund Holm,Simon Francis Thomsen
Jesper Grønlund Holm
Psoriasis (PsO) is one of the most common chronic inflammatory skin diseases with a world prevalence of 2%-4%. The increasing knowledge of the mechanisms driving PsO has raised focus on existing links to metabolic syndrome and type 2 diabet...
Psoriasis and sexual dysfunction: links, risks, and management challenges [0.03%]
银屑病与性功能障碍：关联、风险及管理挑战
Gleison V Duarte,Humberto Calmon,Gabriela Radel et al.
Gleison V Duarte et al.
According to the WHO, sexual health is not merely the absence of disease. Sexual dysfunction may be present in 40.8% of psoriasis patients, furthermore, 68% prevalence was found in Brazilian women with psoriasis. The moderate prevalence of ...
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date [0.03%]
risankizumab治疗斑块状银屑病的潜力：迄今为止的证据综述
Álvaro Machado,Tiago Torres
Álvaro Machado
Psoriasis is a common chronic immune-mediated skin disease, with systemic involvement and significant impact in patients' quality of life. Several highly specific treatments have been developed over the years, such as tumor necrosis factor-...